Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Rekombinanter CD3 Antikörper

Der Ratte Monoklonal Anti-CD3 Antikörper wurde für FACS, IHC, WB, ELISA, ICC und in vivo validiert. Er ist geeignet, CD3 in Proben von Maus zu detektieren.
Produktnummer ABIN7795305

Kurzübersicht für Rekombinanter CD3 Antikörper (ABIN7795305)

Target

Alle CD3 Antikörper anzeigen
CD3

Antikörpertyp

Recombinant Antibody

Reaktivität

  • 240
  • 113
  • 41
  • 20
  • 17
  • 10
  • 8
  • 8
  • 7
  • 7
  • 7
  • 3
  • 3
  • 2
  • 2
  • 1
Maus

Wirt

  • 293
  • 69
  • 20
  • 9
  • 6
  • 4
Ratte

Klonalität

  • 387
  • 5
  • 3
  • 1
Monoklonal

Konjugat

  • 122
  • 43
  • 31
  • 27
  • 24
  • 13
  • 10
  • 8
  • 8
  • 8
  • 6
  • 6
  • 5
  • 5
  • 5
  • 5
  • 4
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser CD3 Antikörper ist unkonjugiert

Applikation

  • 348
  • 96
  • 67
  • 61
  • 53
  • 46
  • 41
  • 27
  • 25
  • 10
  • 8
  • 7
  • 7
  • 6
  • 6
  • 6
  • 4
  • 4
  • 4
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
Flow Cytometry (FACS), Immunohistochemistry (IHC), Western Blotting (WB), ELISA, Immunocytochemistry (ICC), In vivo Studies (in vivo)

Güteklasse

In vivo Grade

Klon

17A2
  • Expressionssystem

    Mammalian cells

    Verwendungszweck

    In vivo Grade Recombinant Anti-mouse CD3 Monoclonal Antibody (Clone: 17A2), Rat IgG2b Kappa

    Produktmerkmale

    The antibody binds to CD3 epsilon of the T cell receptor-CD3 complex found only on mature T cells and medullary thymocytes. An interaction between T cells, the antibody, and monocytes causes T-cell activation (mitogenesis) in vitro. On the other hand, the antibody blocks the unique association between the antigen receptor and CD3, and both the generation and function of cytotoxic T cells. After an initial dose of the antibody, T cells disappear from the circulation within minutes to hours. During treatment with the antibody, T cells bearing the usual array of surface molecules (CD2, CD4, and CD8) reappear in the peripheral blood circulation but these cells are devoid of CD3. After another 48 hours without the antibody, the normal array of surface molecules including CD3 appear again on all T cells. The selective removal of CD3 by internalization is thought to be the key mechanism of action of the antibody. Comodulation of the antigen receptor with CD3 explains the immunoblocking action of the antibody in vivo. The antibody is ineffective clinically if the CD3 target molecule is not modulated. The antibody is effective for induction of immunosuppression and for treating initial and steroid-resistant rejections.

    Aufreinigung

    Protein A or G affinity column

    Reinheit

    >95 % by reducing SDS-PAGE

    Endotoxin-Niveau

    < 1 EU per 1 mg of the protein by the LAL method

    Isotyp

    IgG2b, kappa
  • Applikationshinweise

    Optimal working dilution should be determined by the investigator.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Liquid

    Konzentration

    > 3 mg/mL

    Lagerung

    4 °C,-20 °C

    Informationen zur Lagerung

    Short time 2 to 8°C as supplied. Long time -20°C to -70°C as supplied.
  • Target

    CD3

    Andere Bezeichnung

    CD3

    Pathways

    T-Zell Rezeptor Signalweg, Ubiquitin Proteasome Pathway
Sie sind hier:
Chat with us!